ENXTPA:VETOPharmaceuticals
Vetoquinol (ENXTPA:VETO) Discusses 2025 Half-Year Financials In Recent Board Meeting
Vetoquinol (ENXTPA:VETO) recently convened a board meeting on September 9 to review and approve its financial statements for the first half of 2025. Despite this significant internal event, the company's stock price remained flat over the last week, aligning with the broader market trends. Major U.S. stock indices like the Dow Jones and S&P 500 reached record highs, buoyed by encouraging inflation data and interest rate cut hopes. While the neutral movement of Vetoquinol's share price mirrors...